Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...
Actos bladder cancer lawsuits continue, with a new complaint filed by a resident of Tennessee. The national law firm, Parker Waichman LLP, represents the Tennessee man who alleges that Actos caused his bladder cancer.
The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...
A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...
More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.
In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects.
These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...
Medical device giant, Medtronic Inc., is settling charges over kickbacks to doctors. The firms just agreed to pay $23.5 million to settle claims it paid physicians kickbacks in exchange for their use of its pacemakers and defibrillators, according to a U.S. Justice Department announcement yesterday.
The company was accused of seeking ...
Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, such as the heart attacks and strokes it is ...
A new study from Finland has confirmed previous findings about a link between the use of cholesterol-lowering statin drugs and higher risk of Type 2 diabetes. This study, published in the journal Diabetologia, avoided some of the limitations of earlier … Continue reading →
New Canadian research shows that cholesterol-lowering statin drugs may raise the risk of developing cataracts, a clouding of the lens of the eye. While statins such as Zocor (simvastatin), Crestor (rosuvastatin), and Lipitor (atorvastatin) protect many people from heart attack … Continue reading →
According to a study just published online in the medical journal the Lancet, cholesterol-lowering statin drugs can directly increase the risk of diabetes. While statins have previously been associated with higher rates of Type 2 diabetes, it was not clear … Continue reading →
Recently published research reports serious design flaws in many of the pharmaceutical studies involving animals that precede drug trials in humans. A research team led by pharmacologist Lisa Bero of the University of California, San Francisco, analyzed animal studies of … Continue reading →
A new study has found that statins, used to lower blood cholesterol levels, may reduce exercise benefits for overweight adults. Statins rank among the best selling drugs in the world and are typically prescribed to people with obesity, diabetes, and … Continue reading →
A recent BMJ article reviewed the connection between statin medications and kidney damage. The just-published article reviewed data from over 2 million patient records dated from 1997 to 2008, said the Drug Safety Monitor. Records originated from Canadian provinces and … Continue reading →
People who use statins to lower their cholesterol may face a higher risk of developing age-related cataracts, according to a new study that appears in the August issue of Optometry and Vision Science. According to the study, the association between … Continue reading →
Statin drugs prescribed to lower cholesterol levels are more likely to cause severe muscle injuries when taken at higher doses or when more potent forms of the drug are used. According to a ScienceDaily.com report on a new study from … Continue reading →
Cholesterol-lowering statins may leave patients fatigued, according to a new study. Statins are a class of prescription drugs used in combination with diet and exercise to lower the blood levels of low-density lipoprotein (LDL) cholesterol—so-called bad cholesterol. The research found … Continue reading →
The U.S. Food and Drug Administration (FDA) issued a warning concerning statin interactions with HIV and hepatitis C medications. The notification involved interactions between protease inhibitors and certain statin drugs, including Lipitor (Atorvastatin), Mevacor (Lovastatin), Crestor (Rosuvastatin), and Zocor (Simvastatin). … Continue reading →